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2 
Abstract 18 
The role of electrostatic interactions in the separation of pharmaceuticals by a loose 19 
nanofiltration (NF) membrane was examined.  While retention of the non-ionizable 20 
pharmaceutical carbamazepine was relatively independent of the solution chemistry, 21 
retention of the ionizable pharmaceuticals sulfamethoxazole and ibuprofen was strongly 22 
influenced by the solution pH and ionic strength.  This finding is consistent with previous 23 
results investigating the effects of solution pH and ionic strength on the retention of 24 
proteins and organic acids.  Pharmaceutical retention increases dramatically as the 25 
compound transforms from a neutral to a negatively charged species when the solution 26 
pH increases above its pKa value.  In contrast, solution ionic strength suppresses the 27 
double layer or the Debye screening length and therefore reduces the effectiveness of 28 
electrostatic interaction as a major retention mechanism by the loose NF.  However, 29 
because of the formation of a hydrated layer around the charged functional groups of the 30 
pharmaceuticals and the fact that at a sufficiently high ionic strength the Debye length 31 
approaches a relatively constant value, this reduction in retention is relatively small.  As a 32 
result, even at comparatively elevated ionic strengths, retention of the negatively charged 33 
sulfamethoxazole and ibuprofen by the loose NF membrane is considerably high. 34 
Keywords: nanofiltration, pharmaceutically active compounds, charge repulsion, 35 
retention mechanisms 36 
1 Introduction 37 
In recent years, there has been considerable research effort focusing on removing specific 38 
individual contaminants instead of the surrogate and often ill-defined water quality 39 
indicators.  This paradigm shift is mainly driven by stricter environmental regulations and 40 
legislation, greater need to utilize non-traditional water resources including water 41 
reclamation and water recycling. Further, partial removal of such compounds in water and 42 
wastewater treatment, and particularly the availability of advanced treatment technologies 43 
such as advanced oxidation, carbon adsorption, and membrane filtration as well as hybrid 44 
processes have contributed to a greater interest in understanding removal mechanisms.  45 
The centre of attention amongst such contaminants is a group known as pharmaceutically 46 
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active compounds (PhACs), which has been a major concern due to their widespread 47 
occurrence of sub microgram per liter concentrations in the aquatic environment.  Most 48 
pharmaceuticals are not fully assimilated and hence excreted after administration to 49 
humans or animals.  They can resist biodegradation during conventional wastewater 50 
treatment processes to a considerable extent, depending on their physicochemical 51 
characteristics.  Several pharmaceuticals such as carbamazepine are highly persistent and 52 
are not removed at all by wastewater treatment plants (WWTPs) [1, 2].  In other cases, the 53 
high degradation rate of the pharmaceuticals can be virtually offset by their continuous 54 
introduction into the environment.   55 
Research to date has clearly indicated the abundance of PhACs in sub microgram per liter 56 
concentrations in secondary treated effluent, surface water, ground water, and in extreme 57 
cases even in drinking water [3-5].  Because pharmaceuticals are designed to be 58 
biologically active, they have the potential to induce chronic sublethal effects on living 59 
organisms and any of such adverse health effects can instill serious consequences.  It is 60 
therefore essential to prevent contaminants such as PhACs from entering the aquatic 61 
environment [4], and particularly so prior to potable water recycling.   62 
Solute separation in a nanoporous membrane filtration process is driven mostly by size 63 
exclusion (also known as steric interactions) and electrostatic interactions.  The former is 64 
often described by the hydrodynamic model where porous membranes are presented as 65 
bundles of straight, narrow, cylindrical pores and steric interactions are taken into account 66 
to correct for the hindered convection and diffusion of uncharged solute within the 67 
membrane pores [6].  Using the extended Nernst-Planck equation to include the Donnan 68 
or dielectric exclusion due to interactions between the membrane charged surface and the 69 
charged solute, several models has been developed to describe the latter.  Amongst the 70 
early versions of these, the space charge model proposed by Wang et al. [7] assumed ions 71 
as point charges and focused almost exclusively on the electrostatic interactions between 72 
solute and the membrane charged surface.  Recently, a more rigorous description of the 73 
dielectric exclusion behavior has also been developed for both monovalent and 74 
multivalent salts by Bowen and Welfoot [8].  Because mineral salts were used as model 75 
solutes in most of these studies, a knowledge gap remains with respect to electrostatic 76 
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interactions between charged organic compounds, particularly trace organics, and the 77 
membrane charged surface.  Over the last few decades, due to commercial interest in 78 
several organic compounds such as proteins and lactate salts, contributions of electrostatic 79 
interactions to the transport of these solutes in porous membrane systems have also been 80 
the subject of extended research.  Several studies have shown, for example, that protein 81 
transport is a function of the membrane surface charge characteristics and protein 82 
retention increases significantly under conditions where the membrane and protein have 83 
the same charge due to increased electrostatic repulsion.  Furthermore, there is substantial 84 
experimental evidence that these electrostatic interactions between proteins and the 85 
membrane surface are dependent of the solution chemistry, such as pH and ionic strength.  86 
For example, Burns and Zydney [9, 10] and Nakao et al. [11] evaluated the effect of 87 
solution pH on the passage of proteins through ultrafiltration membranes and found that 88 
the maximum passage was typically attained near the protein isoelectric point where the 89 
protein has no net electrical charge.  Millesime et al. [12] reported a significant decrease 90 
in the retention of bovine serum albumin and lysozyme from as high as 100% to only 91 
35% and 10%, respectively, as the solution ionic strength increased to 1 M by adding 92 
NaCl to the feed solution.  This is consistent with the results reported earlier by Pujar and 93 
Zydney [13].  Both groups attributed this behavior to the decrease in electrostatic 94 
repulsion at high ionic strength.  95 
To date, most theoretical analyses on the effects of electrostatic interactions on organic 96 
solute transport in membrane filtration were carried out with proteins [9-11, 13] and to a 97 
lesser extent lactate salts as model solutes [14, 15].  There is currently a lack of 98 
information with respect to the influence of solution chemistry on the separation process 99 
of charged pharmaceuticals, particularly by loose NF membranes.  Although the transport 100 
behavior of small organic compounds may follow some of the trends observed for that of 101 
proteins, there are several fundamental differences in their physicochemical 102 
characteristics.  First, proteins are relatively large macromolecules.  While a protein 103 
molecule can contain multiple charged moieties, small organic compounds such as 104 
pharmaceuticals typically consist of a single charged functional group.  Consequently, the 105 
conformation and size of a macromolecule can vary considerably due to intra-molecular 106 
electrostatic interactions between its charged groups.  On the other hand, given the much 107 
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smaller size of pharmaceuticals, the contribution of the hydrated layer may play a role in 108 
their passage through the membrane pores.  It is also noteworthy that studies investigating 109 
the separation of proteins and lactate salts often employed a very high background 110 
electrolyte concentration of up to 1M, typical to that of an industrial application rather 111 
than the water recycling context.     112 
Given the significant role that membrane filtration has taken on in the water industry [16], 113 
especially for water recycling, the use of nanofiltration (NF) membranes for the removal 114 
of trace organics has been intensively investigated [17-21].  None of these studies, 115 
however, have examined the role of electrostatic interactions in the removal of PhACs by 116 
loose NF membranes.  The objective of this study is to examine the role of electrostatic 117 
interactions in the removal of pharmaceuticals by such a loose polymeric NF membrane.  118 
Both the membrane and the pharmaceuticals were characterized in detail.  The membrane 119 
retention behavior was related to the physicochemical properties of the pharmaceuticals 120 
and the membranes as well as to the solution chemistry.  Variation is solution chemistry 121 
involved pH, ionic strength, and presence of divalent cations.  On the basis of the results, 122 
the role of electrostatic interactions in the nanofiltration of the selected pharmaceuticals 123 
was elucidated and discussed.   124 
2 Materials and Methods 125 
2.1 Nanofiltration membrane 126 
Flat sheet samples of a loose thin film composite NF membrane  denoted TFC-SR2 127 
(Koch Membrane Systems, San Diego, CA)  were used in this investigation.  The 128 
membrane consists of a thin polyamide skin layer on top of a microporous polysulfone 129 
support.  This membrane was selected because of its low salt and high organic matter 130 
retention which makes it a very desirable membrane if desalination or hardness removal is 131 
not required.  It was received as flat sheet sample and was stored dry at 4 oC.   132 
2.2 Pharmaceutically active contaminants (PhACs) 133 
Three common pharmaceuticals  sulfamethoxazole, carbamazepine, and ibuprofen  134 
representing three different drug categories, were selected for this study.  Figure 1 depicts 135 
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the structures of these compounds.  The compounds were purchased from Sigma-Aldrich 136 
(Saint Louis, MO).  The purity of these chemicals was reported to be 99 % or higher.  137 
Sulfamethoxazole is an important member of the sulfonamide antibacterial category and 138 
is probably the most frequently used antibiotic; carbamazepine is one of the most widely 139 
used anti-epileptic drugs; and ibuprofen is a common anti-inflammatory agent.  Because 140 
they belong to three different drug categories, these pharmaceuticals have quite distinctive 141 
functional groups (Figure 1).  The pharmaceuticals were first dissolved in pure methanol 142 
to make up stock solutions of 1 g/L.  The stock solutions were stored at < 4 oC and were 143 
used within 1 month. 144 
[Figure 1] 145 
2.3 Cross flow membrane filtration system and filtration protocol 146 
A laboratory-scale membrane filtration unit with a rectangular stainless steel crossflow 147 
cell (effective membrane area of 40 cm2 and a channel height of 2 mm) was used for the 148 
experiments.  The temperature of the test solution was controlled using a chiller/heater 149 
(Neslab RTE 7) equipped with a stainless steel heat exchanger coil.  Permeate flow was 150 
measured by a digital flow meter (Optiflow 1000, Agilent Technologies, Palo Alto, CA) 151 
connected to a PC, and the cross flow/feed flow was monitored with a rotameter. 152 
Prior to each experiment, the membrane was stabilized at 12 bar using DI water for 153 
approximately 16 hours until there was no further variation in permeate flux.  The feed 154 
reservoir temperature was kept constant at 20 ± 0.1 oC throughout the experiment.  Both 155 
permeate and retentate were recirculated back to the feed reservoir.  In all filtration 156 
experiments, the background electrolyte solution contained 20 mM NaCl and 1 mM 157 
NaHCO3, and, unless otherwise stated, the pH was kept at 8.  158 
Prior to experimenting with pharmaceuticals, the DI water used for membrane 159 
compaction was replaced with 7 liters of fresh DI water.  The cross flow velocity and 160 
permeate flux were adjusted to 30.4 cm/s and 15 μm/s (54 Lm−2h−1), respectively.  161 
Pharmaceuticals were then spiked into the feed reservoir to make up a concentration of 162 
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500 μg/L.  Approximately 1.5 mL of feed and permeate samples were taken for analysis 163 
at specified time intervals.   164 
For experiments with variable pH, the solution was adjusted to pH 10.5 by addition of a 165 
proper volume of 1 M NaOH.  The pH was then incrementally dropped to 3.5 using 166 
stepwise additions 1 M HCl.  For experiments with variable electrolyte concentration, the 167 
initial solution contained 1 mM NaHCO3 and the pH was kept at 8.  NaCl solution (1 M) 168 
and CaCl2 (0.2 M) were then added to the feed reservoir to incrementally increase the 169 
electrolyte concentration as required.  The system was equilibrated for 1 hour prior to 170 
sample collection at each pH or electrolyte concentration value.  Observed retention is 171 
defined as R = 100×(1 − CP/CF ), where CP and CF are the permeate and the feed 172 
concentrations, respectively.   173 
2.4 Analytical methods 174 
A Shimadzu HPLC system (Shimadzu, Kyoto, Japan) equipped with a Supelco Drug 175 
Discovery C-18 column and a UV detector was used to analyze pharmaceutical 176 
concentration in the feed and permeate samples.  Detection wavelengths for 177 
sulfamethoxazole and carbamazepine were set at 280 nm, and for ibuprofen at 225 nm.  178 
DI water (buffered with 0.025 M KH2PO4) and acetonitrile were used as the mobile 179 
phase.  The mobile phase was delivered at a constant flow rate of 1 mL/min with a 180 
gradient set in accordance with the chromatographic behavior of the respective analytes.  181 
Analysis was carried out immediately following the nanofiltration experiments. 182 
3 Results and discussion 183 
3.1 Membrane characteristics 184 
Characteristics of the TFC-SR2 membrane have been previously described.  It was 185 
reported to be relatively hydrophilic with contact angle of approximately 20o measured 186 
using the sessile drop technique [22]. The membrane retains a small percentage of 187 
calcium while sodium retention is virtually negligible [22].  Pore size measurement 188 
following the procedure described in our previous publication [23] indicates that this 189 
membrane has a relatively open pore size, with an average pore radius determined of 0.64 190 
nm.  Despite being a loose NF membrane, the TFC-SR2 membrane has a relatively high 191 
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natural organic matter removal of 70-85% [24], which is the characteristic of the SR 192 
series.  High flux and high salt passage in combination with a moderate to high organic 193 
matter removal make the TFC-SR2 membrane particularly attractive for water recycling 194 
as well as surface water treatment.  In such applications, salt removal is unnecessary and 195 
often undesirable due to the energy loss with the buildup of osmotic pressure and the 196 
production of a brine that requires further treatment and disposal.   197 
As expected, sodium chloride retention (estimated by conductivity measurements) by the 198 
TFC-SR2 membrane is very small, yet the membrane attains a considerable negative 199 
charge at pH values above pH 5 (Figure 2).  Below pH 5, the membrane zeta potential 200 
varies sharply as a function of pH, from slightly positive at pH 2.5 to −10 mV at pH 5.  201 
This is due to the deprotonation or protonation of the membrane functional moieties, 202 
which in this case consist of predominantly carboxylic and amine groups [25].  It is 203 
noteworthy that the membrane zeta potential can provide a good indicative parameter to 204 
assess the membrane surface charge density [25, 26].  The membrane zeta potential or 205 
charge density does have a small but discernible influence on the retention of sodium 206 
chloride (Figure 2).  This observation suggests that electrostatic interaction plays a small 207 
role in the separation process of ionic species by the TFC-SR2 membrane.  Retention is 208 
smallest near the isoelectric point of the membrane.  Due to the relatively large pore 209 
radius of the membrane (0.64 nm) with regard to the hydrated radii of the chloride or 210 
sodium ions, which have been reported to be 0.20 and 0.18 nm [27], respectively, the 211 
effect is relatively small.  However, as will be discussed in a later section, electrostatic 212 
interactions can contribute substantially to the retention of charged organic molecules.  213 
[Figure 2] 214 
3.2 Physicochemical properties of the selected PhACs 215 
Because of the differences in functional groups, the three pharmaceuticals selected for 216 
this study exhibit markedly different physicochemical properties (Table 1).  While 217 
carbamazepine is uncharged at common pH conditions typical of natural water or 218 
wastewater, both ibuprofen and sulfamethoxazole exhibit a wide variation in speciation 219 
(or charge) and physicochemical properties.  At pH below its pKa value (pH 4.9), 220 
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ibuprofen is a neutral species.  Above this pKa value, ibuprofen attains a negative charge.  221 
Speciation of sulfamethoxazole as a function of pH has been described elsewhere [28].  222 
This pharmaceutical can exist in positive, neutral, as well as negative forms as it 223 
possesses two ionizable amine groups.  At pH above the compound’s second pKa value 224 
(pH 5.7), sulfamethoxazole exists predominantly as a negatively charged species.  It is 225 
noteworthy that values of the hydrophobicity presented in Table 1 are assumed to 226 
represent characteristics of the compounds in their neutral form.  Data for other pH values 227 
can be obtained by considering the effective partition coefficient (commonly known as 228 
logD) for the dissociative systems and can be found in databases such as SciFinder.  229 
Variations in charge and other physicochemical properties as a function of pH may have 230 
important implications for the separation mechanisms of these pharmaceuticals. 231 
[Table 1] 232 
3.3 Steric hindrance and electrostatic interactions 233 
Figure 3 presents the concentration of sulfamethoxazole, carbamazepine, and ibuprofen 234 
in both permeate and feed solutions as a function of time during filtration with the TFC-235 
SR2 membrane at pH 4.0.  Because of their low hydrophobicity, both sulfamethoxazole 236 
and carbamazepine do not adsorb to the membrane at these experimental conditions, 237 
which is evident from their constant feed concentrations for the duration of the 238 
experiments.  Interestingly, despite the fact that the TFC-SR2 has a relatively hydrophilic 239 
surface, ibuprofen adsorbs considerably to this membrane, which manifests itself as 240 
decreasing feed concentration (from 500 to about 300 μg/L) until equilibrium is reached 241 
(Figure 3).  In its neutral form, ibuprofen is a highly hydrophobic compound as reflected 242 
by its high logKow value (Table 1) and this observed adsorption can probably be attributed 243 
to hydrophobic interactions between ibuprofen and hydrophobic domains within the 244 
membrane polymer matrix.  It is noteworthy that the molecular size of ibuprofen (Table 245 
1) is considerably smaller than the average pore size of the TFC-SR2 membrane, and 246 
therefore, adsorption is not confined to the membrane surface and hence can take place 247 
throughout the polymer structure.  As can be seen in Figure 3, this adsorption initially 248 
appears as a low permeate concentration (and hence high retention) while equilibrium is 249 
reached after about 2.5 hours of filtration.  250 
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[Figure 3] 251 
At equilibrium when no further adsorption is observed, ibuprofen retention of 252 
approximately 35% can be inferred from Figure 3.  This is significantly higher than the 253 
retentions of both sulfamethoxazole and carbamazepine, which are practically negligible 254 
despite the fact that these pharmaceuticals have about the same molecular size (Table 1).  255 
As discussed previously, at this experimental condition of pH 4, sulfamethoxazole and 256 
carbamazepine exist in their neutral form while 10% of ibuprofen still carries a negative 257 
charge.  Consequently, this can be a major factor for the difference in retention between 258 
ibuprofen and the other two pharmaceuticals.  Further reason for this can be due to the 259 
adsorption of the neutral ibuprofen onto the membrane and pore surfaces, leading to a 260 
higher observed retention, some of which may also be related to pore size reduction.  261 
Similar observation has also been made when the effects of adsorption on protein 262 
retention by ultrafiltration membranes was evaluated [29].  In addition, a sufficiently high 263 
dipole moment (above 3 D) can induce an electrostatic attraction between the membrane 264 
surface and the polar centers of the molecule [30].  Because the dipole moment of both 265 
sulfamethoxazole and carbamazepine is quite high (Table 1), the molecules tend to 266 
approach the membrane pore head on which results in a lower retention [30].   267 
At pH 8, where both sulfamethoxazole and ibuprofen are negatively charged 268 
(carbamazepine remains neutral and hence has not been investigated), electrostatic 269 
attraction induced by the compound’s polarity can be overcome by the electrostatic 270 
repulsion (Figure 4).  Due to electrostatic repulsion (or charge exclusion), 271 
sulfamethoxazole is retained to some extent while the retention of ibuprofen is 272 
considerably higher than that at pH 4.   It is noteworthy that at this pH, ibuprofen does not 273 
adsorb to the membrane as indicated by the constant feed and permeate concentrations 274 
throughout the experiment.   275 
[Figure 4] 276 
The effect of speciation (in other words the variation in charge of a species as a function 277 
of pH) on retention is further illustrated in Figure 5.  Because carbamazepine is neutral at 278 
all pH values in examined here, carbamazepine retention is constant and independent of 279 
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solution pH (and membrane charge).  In contrast, retention of both sulfamethoxazole and 280 
ibuprofen varies markedly, resembling their speciation curves as a function of pH, with 281 
the exception of high ibuprofen retention at low pH due to adsorption.  This is consistent 282 
with several other studies where the nanofiltration of lactic or amino acids was 283 
investigated [15, 31-33].    284 
[Figure 5] 285 
The presented results indicate a distinctive difference between the retention behaviors of 286 
ionizable organic compounds and inorganic salts such as NaCl.  As reported in an earlier 287 
section, sodium chloride retention was small and relatively constant over a wide pH range 288 
from 2 to 8 (Figure 2).  Again, one can speculate that the retention behavior is attributed 289 
to the relative size difference between the solute and the membrane pore.  290 
Sulfamethoxazole and ibuprofen are considerably larger than the chloride ion (Table 1).   291 
It is also interesting to point out that ibuprofen retention is consistently higher than that of 292 
sulfamethoxazole.  This can possibly be explained by the fact that ibuprofen is an organic 293 
acid.  Therefore, when dissociated, the negative ibuprofen species has a higher charge 294 
density than that of sulfamethoxazole, which is deprotonated via the dissociation of an 295 
amine group.  Such a higher charge density would result in not only an increase in charge 296 
repulsion, but also a larger molecule hydrated size. 297 
3.4 Influence of background electrolyte: Monovalent Salt 298 
Solution ionic strength is directly related to the Debye length or the double layer thickness 299 
of the charged solutes and at the membrane surface, which in turn governs electrostatic 300 
interaction in NF processes.  It is hence expected to influence the separation of charged 301 
solutes by NF membranes to some extent.  Indeed, experimental data at pH 8 for the two 302 
charged compounds, presented in Figure 6, appear to strongly support this hypothesis.  303 
As ionic strength increases (represented by an increase in sodium chloride concentration), 304 
the Debye length becomes smaller.  In other words, electrostatic interaction between the 305 
membrane and charged molecules is screened resulting in lower electrostatic repulsion 306 
and hence reduced retention.  However, it should be noted that the Debye length is a 307 
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characteristic length for the range of electrostatic interaction and does not represent the 308 
actual dimension of a charged particle or surface.  One can imagine the Debye length as 309 
an extension of a membrane pore (or more precisely a surface functional group) and of a 310 
molecule (or its charged functional group).  One can further picture that this Debye length 311 
‘diminishes’ the effective size of a pore or increases the effective size of a molecule.  A 312 
qualitative picture of such an effect is shown in Figure 7.  If dimensions are of the right 313 
proportions, that is if Debye length is of the same order of magnitude as the size 314 
difference between molecule and pore, then such a variation may be a determining factor 315 
in the retention of a charged molecule by a charged membrane. It is noted that Figure 7 316 
presents a conceptual model and does not show the Debye length overlap. 317 
[Figure 6] 318 
[Figure 7] 319 
It can also be confirmed that this influence of ionic strength on retention is absent when 320 
the solute is neutral at pH 4 (Figure 8).  Consequently, the molecule retention is constant 321 
as sodium chloride concentration in the feed increase up to 70 mM (or 4095 mg/L).  322 
While an increase in salt concentration can occur for varying feed waters, for most 323 
nanofiltration and reverse osmosis membranes that retain salt such an increase in salt 324 
concentration also occurs in the polarized layer near the membrane surface.  325 
[Figure 8] 326 
3.5 Influence of background electrolyte: Divalent Salts 327 
As expected, the influence of CaCl2 concentration on the retention of negatively charged 328 
pharmaceuticals is more dramatic (Figure 9).  Calcium is a divalent ion and thus is more 329 
effective in screening the molecule and membrane charge.  Furthermore, calcium can also 330 
reduce the membrane charge because of its binding capacity to the membrane surface 331 
functional groups.  As calcium chloride concentration increases to 8 mM, retention of the 332 
negatively charged pharmaceuticals appears to reach a plateau value while a concentration 333 
of 80 mM of NaCl is necessary for sulfamethoxazole and ibuprofen retention to reach a 334 
relatively constant value (Figure 6).   335 
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[Figure 9] 336 
In both cases, this plateau retention value is significantly higher than the retention of 337 
neutral sulfamethoxazole and ibuprofen (Figures 3 and 5).  This is possibly due to a 338 
limitation in the compressibility of the double layer at increasing ionic strength.  As 339 
demonstrated in Figure 7, the Debye length decreases as the ionic strength or salt 340 
concentration increases following an exponential decay pattern.  At concentration above 341 
80 mM for NaCl, an increase in ionic strength only results in a small incremental decrease 342 
in the Debye length. Similar conclusion can also be inferred for CaCl2, although in this 343 
case, CaCl2 reduces the Debye length more effectively and therefore above 8 mM of 344 
CaCl2, the Debye length decrease is negligible as CaCl2 concentration is further increased.  345 
A further consideration is the formation of a hydrated layer around the negatively charged 346 
moiety of the pharmaceuticals and the membrane functional groups.  While very little is 347 
known about the hydration of polymers and organic molecules, this effect possibly results 348 
in a considerable increase in their apparent size.  For example, the thickness of a 349 
monolayer of water molecules is approximately 0.1 nm.  Although the hydration energy 350 
or hydrated radius of the negatively charged pharmaceuticals investigated here are not 351 
available in the literature, it appears that the hydration energy of the anions is stronger 352 
than that of the cations [26].  Consequently, hydration may also be a considerable factor 353 
contributing to the difference in retention at a sufficiently high ionic strength between 354 
neutral and negatively charged pharmaceuticals as observed in Figures 8 and 9. 355 
4 Conclusion 356 
Results reported here indicate that retention of the ionizable pharmaceuticals at the low 357 
concentrations examined is strongly influenced by solution pH and ionic strength.  These 358 
results are consistent with previous studies on retention of proteins and organic acids such 359 
as lactic acid.  Solution pH governs the speciation (or charge) behavior of the compound 360 
and therefore the retention mechanisms.  Pharmaceutical retention increases dramatically 361 
as the compound transforms from a neutral to a negatively charged species as solution pH 362 
increases above its pKa value.  Ionic strength screens the molecule and membrane charges 363 
and therefore reduces the effectiveness of electrostatic repulsion as a major retention 364 
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mechanism by the loose NF membrane.  However, such a reduction is relatively small and 365 
at a comparatively high ionic strength, retention of the negatively charged 366 
sulfamethoxazole and ibuprofen by the loose NF membrane remains considerably high at 367 
50-85%.  This is probably attributed to the incompressibility of the Debye length at a 368 
sufficiently high ionic strength (about 80 mM) and the formation of a hydrated layer 369 
surround the negatively charged moieties of the pharmaceuticals. 370 
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Table 1. Physicochemical Properties of Pharmaceuticals a [34], b [35], c [36], d 493 
Calculated by the Wilke-Chang and the Stokes-Einstein equations [37].  These 494 
values present the size of the neutral compounds, e estimated using HyperChem 495 
7.0 [38], f [39], g [40]. 496 
 497 
Pharmaceutical MW (g/mol) pKa
 
Stokes 
radius 
(nm) 
Log 
Kow 
Dipole 
Moment (D) 
Sulfamethoxazole 253.3 
pKa1 = 1.7 a 
pKa2 = 5.6 a, 5.7 b 
0.38 d 0.89 c 5.4 e 
Carbamazepine 236.3 2.3 c 0.37 d 2.45 c 3.6 e 
Ibuprofen 206.3 4.4 e - 4.9 c 0.34 d 3.5 
c, 
4.13 f 1.8 
g 
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FIGURE CAPTIONS 498 
Figure 1.  Chemical structures of the three pharmaceuticals used in this study. 499 
Figure 2.   Zeta potential of the TFC-SR2 membrane (in a background electrolyte solution 500 
containing 20 mM NaCl and 1 mM NaHCO3) and conductivity retention (feed solution 501 
contained 20 mM NaCl and 1 mM NaHCO3) by the TFC-SR2 membrane as a function of 502 
pH. 503 
Figure 3.  Feed and permeate concentration of the uncharged (a) sulfamethoxazole, (b) 504 
carbamazepine, and (c) ibuprofen species as a function of filtration time for the TFC-SR2 505 
membrane.  The feed solution contained 500 µg/L of the corresponding pharmaceuticals 506 
in a background electrolyte solution containing 20 mM NaCl and 1 mM NaHCO3.  Other 507 
experimental conditions were as follows: cross flow velocity = 30.4 cm/s, permeate flux = 508 
15 µm/s (54 Lm−1h−1), pH = 4, and temperature = 20 oC. 509 
Figure 4.  Feed and permeate concentration of the negatively charged (a) 510 
sulfamethoxazole and (c) ibuprofen species as a function of filtration time for the TFC-511 
SR2 membrane.  The feed solution contained 500 µg/L of the corresponding 512 
pharmaceuticals in a background electrolyte solution containing 20 mM NaCl and 1 mM 513 
NaHCO3.  Other experimental conditions were as follows: cross flow velocity = 30.4 514 
cm/s, permeate flux = 15 µm/s (54 Lm−1h−1), pH = 8, and temperature = 20 oC. 515 
Figure 5.  Retention of sulfamethoxazole, carbamazepine, and ibuprofen by the TFC-SR2 516 
as a function of the solution pH.  The feed solution contained 500 µg/L of the 517 
corresponding pharmaceuticals in a background electrolyte solution containing 20 mM 518 
NaCl and 1 mM NaHCO3.  Other experimental conditions were as follows: cross flow 519 
velocity = 30.4 cm/s, permeate flux = 15 µm/s (54 Lm−1h−1), and temperature = 20 oC. 520 
Figure 6.  Retention of anionic sulfamethoxazole and ibuprofen by the TFC-SR2 as a 521 
function of the solution NaCl concentration.  The feed solution contained 500 µg/L of the 522 
corresponding pharmaceuticals in a background electrolyte solution containing 1 mM 523 
NaHCO3 and varied concentration of NaCl.  Other experimental conditions were as 524 
20 
follows: cross flow velocity = 30.4 cm/s, permeate flux = 15 µm/s (54 Lm−1h−1), pH = 8, 525 
and temperature = 20 oC. 526 
Figure 7.  The calculated Debye length as a function of the solution NaCl concentration 527 
and a schematic description of the interplay between the Debye length of a charged 528 
molecule and an idealized membrane pore (a) relatively high retention at low ionic 529 
strength and (b) lower retention at high ionic strength. 530 
Figure 8.  Retention of the uncharged sulfamethoxazole and carbamazepine species by the 531 
TFC-SR2 as a function of the solution NaCl concentration.  The feed solution contained 532 
500 µg/L of the corresponding pharmaceuticals in a background electrolyte solution 533 
containing 1 mM NaHCO3 and varied concentration of NaCl.  Other experimental 534 
conditions were as follows: cross flow velocity = 30.4 cm/s, permeate flux = 15 µm/s (54 535 
Lm−1h−1), pH = 4, and temperature = 20 oC. 536 
Figure 9.  Retention of anionic sulfamethoxazole and ibuprofen by the TFC-SR2 as a 537 
function of the solution CaCl2 concentration.  The feed solution contained 500 µg/L of the 538 
corresponding pharmaceuticals in a background electrolyte solution containing 1 mM 539 
NaHCO3 and varied concentration of CaCl2.  Other experimental conditions were as in 540 
Fig. 6. 541 
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